Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
19.59
+0.79 (4.20%)
At close: Jul 21, 2025, 4:00 PM
19.61
+0.02 (0.10%)
After-hours: Jul 21, 2025, 7:48 PM EDT

Rigel Pharmaceuticals Stock Forecast

Stock Price Forecast

The 5 analysts that cover Rigel Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $36.4, which forecasts a 85.81% increase in the stock price over the next year. The lowest target is $23 and the highest is $57.

Price Target: $36.4 (+85.81%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$23$36.4$24$57
Change+17.41%+85.81%+22.51%+190.96%
* Price targets were last updated on May 7, 2025.

Analyst Ratings

The average analyst rating for Rigel Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy222222
Buy000000
Hold333333
Sell000000
Strong Sell000000
Total555555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Maintains
$20$23
HoldMaintains$20$23+17.41%May 7, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$49$55
Strong BuyMaintains$49$55+180.76%Mar 6, 2025
B. Riley Securities
B. Riley Securities
Hold
Maintains
$20$24
HoldMaintains$20$24+22.51%Mar 5, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$57
Strong BuyReiterates$57+190.96%Mar 5, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$57
Strong BuyReiterates$57+190.96%Jan 23, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
205.12M
from 179.28M
Increased by 14.41%
Revenue Next Year
237.88M
from 205.12M
Increased by 15.97%
EPS This Year
1.18
from 0.99
Increased by 19.18%
EPS Next Year
1.96
from 1.18
Increased by 65.96%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
108.62M138.74M115.74M115.88M179.28M205.12M237.88M268.54M
Revenue Growth
83.21%27.73%-16.57%0.12%54.71%14.41%15.97%12.89%
EPS
-1.76-1.05-3.44-1.440.991.181.963.66
EPS Growth
-----19.18%65.96%87.05%
Forward PE
-----16.6010.005.35
No. Analysts
-----886
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High217.1M273.5M294.0M
Avg205.1M237.9M268.5M
Low185.0M217.2M245.6M

Revenue Growth

Revenue Growth20252026202720282029
High
21.1%
33.4%
23.6%
Avg
14.4%
16.0%
12.9%
Low
3.2%
5.9%
3.2%

EPS Forecast

EPS20252026202720282029
High1.323.456.03
Avg1.181.963.66
Low0.911.031.41

EPS Growth

EPS Growth20252026202720282029
High
33.3%
192.7%
207.9%
Avg
19.2%
66.0%
87.1%
Low
-7.9%
-12.8%
-27.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.